0.74 (-%)
As of Dec 04, 2024
Source:
Bluebird Bio, Inc. is a biotechnology company committed to researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on our proprietary lentiviral vector (“LVV”) gene addition platform.
Country | United States |
Headquarters | somerville, massachusetts |
Phone Number | 339-499-9300 |
Industry | manufacturing |
CEO | Andrew Obenshain |
Website | www.bluebirdbio.com |